Panbela Therapeutics, Inc. (OTCMKTS:PBLA – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $0.01 and traded as low as $0.0002. Panbela Therapeutics shares last traded at $0.0002, with a volume of 348 shares.
Panbela Therapeutics Trading Down 98.2%
The firm has a market cap of $971.00, a PE ratio of -0.00 and a beta of 42.77. The business has a fifty day moving average price of $0.01 and a 200 day moving average price of $0.01.
About Panbela Therapeutics
Panbela Therapeutics, Inc is a biotechnology company focused on developing novel therapies for cancer and other serious diseases. The company’s research has centered on treatments that target polyamine metabolism, a biological process associated with tumor growth and cancer progression.
Panbela’s lead investigational product has been ivospemin, formerly known as SBP-101, which has been studied in combination with standard treatments for pancreatic ductal adenocarcinoma and other solid tumors.
Featured Stories
- Five stocks we like better than Panbela Therapeutics
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for Panbela Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Panbela Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
